Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

mPharma

Explore full profile

We make medicines affordable and accessible to patients

Accra, GhanaFounded 2014Biotech & Life Sciences
Valuation $100–500M Latest valuation · 2022
Headcount 100–500 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for mPharma and the history behind them.

About mPharma

mPharma, founded in 2013 by Gregory Rockson, Daniel Shoukimas, and James Finucane, is a health technology company focused on improving access to affordable and quality medications for patients in Africa. The company was born out of the founders' direct experiences with the challenges of accessing prescription drugs in the region. Rockson, the CEO, has a background in public policy and global health, which informed the company's mission. He is joined by CPO Daniel Shoukimas and CTO James Finucane, who bring the technological expertise to build and scale the company's solutions.

Read full description

mPharma's business model revolves around partnering with pharmaceutical manufacturers, insurance companies, healthcare providers, and governments. The company operates a vendor-managed inventory system, which helps pharmacies manage their stock levels efficiently and reduces the risk of stockouts. This is complemented by a financing solution that helps pharmacies procure medicines without large upfront capital investments. For patients, mPharma offers a drug benefits service, making medications more affordable. The company's primary product is a comprehensive pharmacy management software that handles everything from inventory and ordering to patient records and point-of-sale operations. By creating a more efficient and connected supply chain, mPharma aims to become the primary healthcare provider for millions across the continent through its growing network of community pharmacies.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2014
Headquarters
Accra, Ghana
Employees
399
Open positions
3
Dealroom signal
61.7/100
Industry
Health, Fintech
Sub-industry
Pharmaceutical, Mortgages & Lending
Sector
Biotech & Life Sciences, Risk Management, Analytics, Data Analytics, Biotechnology, Sustainable Development Goals, Biotech and Pharma, Hard Tech
Business model
Manufacturing
Client focus
b2b
Investment activity
2 companies, latest Sep 2022
Capital deployed
Preferred round
ACQUISITION

Latest news

Press, funding announcements and product moves mentioning mPharma.

See all news

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Nov 2025 $0 Growth Investment Partners
DEBTDebt Jan 2022 $5M Citibank
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

mPharma website traffic

Latest recorded traffic for mPharma is 3.8K monthly website visits, down 48.6% over the last three months. mPharma's team declined 5.9% over the past year.

Latest monthly visits3.8K 3-month web change-48.6% 1-year team growth-5.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

18 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A3 investors entered at this stage

  • Golden Palm Investments
  • 4DX Ventures
  • Novastar Ventures

Series B and later11 investors entered at this stage

  • CDC Group
  • Jim Breyer
  • Dompé farmaceutici
  • Daniel Vasella
  • Citibank
  • JAM Fund
  • Unbound
  • Northstar
  • Lux Capital
  • TO Ventures
  • Growth Investment Partners

Other known investors1 additional known investor

  • Microsoft for Startups
Team profiled 23 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
16 countries with
team presence
🇳🇬 Nigeria35.3%
🇬🇭 Ghana32.8%
🇰🇪 Kenya12.2%
🏳️ Zambia7.6%
🇺🇬 Uganda2.1%
Top 5 of 16 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about mPharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See mPharma’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.